Patent Yard Sign in
Canadian application, no grantCanada

Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis

CA 2434739 A1 · Owner: Venuta, Salvatore · Inventors: Petrella, Antonello; Venuta, Salvatore; Turco, Maria Caterina

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

It is described a nucleotide sequence and a corresponding protein for which a role and utility in the regulation of programmed cell death or apoptosis are defined. Applications and uses of the sequence and corresponding protein concern all the physiologic and pathologic processes that involve cell death (neoplasias, degenerative diseases, tissue infarcts autoimmune diseases, differentiation processes etc.).

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 10, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 10, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 10, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 10, 2002
GrantedNo grant recorded
Term endedJanuary 10, 2022
Patent numberCA 2434739 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJan 10, 2002Term endedJan 10, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.